Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02034981
Brief Title: Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1 (AcSé)

First Submitted : October 16, 2013
First Submitted that Met QC Criteria : January 10, 2014
First Posted : January 14, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : March 22, 2021
Last Update Posted : March 25, 2021